RESEARCH-USE BIOSIMILAR ANTIBODY
Gumokimab
Monoclonal antibody · IgG1
Gumokimab (AK 111) is a monoclonal antibody targeting IL-17A, which can be used in the study of psoriasis, ankylosing spondylitis. Gumokimab competitively blocks the binding of human IL-17A to IL-17R.
TARGETIL17A
YMonoclonal antibody
CATALOGSC-BS-492
CATALOG NUMBERSC-BS-492
MOLECULAR WEIGHTApprox. 146.52 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Gumokimab (AK 111) is a monoclonal antibody targeting IL-17A, which can be used in the study of psoriasis, ankylosing spondylitis. Gumokimab competitively blocks the binding of human IL-17A to IL-17R.
Gumokimab is a recombinant research-use antibody directed against IL17A.